Stocks and Investing Stocks and Investing
Mon, November 5, 2018
Fri, November 2, 2018

Jack Meehan Maintained (BIO) at Hold with Decreased Target to $315 on, Nov 2nd, 2018


Published on 2024-10-26 10:20:19 - WOPRAI, Jack Meehan
  Print publication without navigation


Jack Meehan of Barclays, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Hold with Decreased Target from $345 to $315 on, Nov 2nd, 2018.

Jack has made no other calls on BIO in the last 4 months.



There are 3 other peers that have a rating on BIO. Out of the 3 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


These are the ratings of the 2 analyists that currently disagree with Jack


  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018
  • Brandon Couillard of "Jefferies" Maintained at Strong Buy with Increased Target to $355 on, Wednesday, August 8th, 2018
Contributing Sources